Literature DB >> 19770620

Increased aldosterone among HIV-infected women with visceral fat accumulation.

Janet Lo1, Sara E D Looby, Jeffrey Wei, Gail K Adler, Steven K Grinspoon.   

Abstract

Increased aldosterone has been associated with obesity and the metabolic syndrome in non-HIV-infected individuals, but aldosterone has not been investigated among HIV-infected patients with increased visceral adipose tissue (VAT). Twenty-four-hour urine aldosterone was assessed among age and BMI-matched HIV-infected women with increased VAT, HIV-infected women without increased VAT and healthy controls. Twenty-four hour urine aldosterone was higher in HIV-infected women with increased VAT and was associated with SBP, VAT and hemoglobin A1c. Increased aldosterone may contribute to the detrimental effects of excess visceral adiposity on blood pressure and glucose homeostasis among HIV patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770620      PMCID: PMC2921849          DOI: 10.1097/QAD.0b013e3283328d3b

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

Review 1.  Primary aldosteronism: cardiovascular, renal and metabolic implications.

Authors:  Gian-Paolo Rossi; Leonardo A Sechi; Gilberta Giacchetti; Vanessa Ronconi; Pasquale Strazzullo; John W Funder
Journal:  Trends Endocrinol Metab       Date:  2008-03-07       Impact factor: 12.015

2.  Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.

Authors:  A Nguyen; A Calmy; V Schiffer; E Bernasconi; M Battegay; M Opravil; J-M Evison; P E Tarr; P Schmid; T Perneger; B Hirschel
Journal:  HIV Med       Date:  2008-01-22       Impact factor: 3.180

3.  Fat distribution in women with HIV infection.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

4.  Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women.

Authors:  T L Goodfriend; D E Kelley; B H Goodpaster; S J Winters
Journal:  Obes Res       Date:  1999-07

5.  Increased cardiovascular disease risk indices in HIV-infected women.

Authors:  Sara E Dolan; Colleen Hadigan; Kathleen M Killilea; Meghan P Sullivan; Linda Hemphill; Robert S Lees; David Schoenfeld; Steven Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2005-05-01       Impact factor: 3.731

6.  Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.

Authors:  Gianluca Colussi; Cristiana Catena; Roberta Lapenna; Elisa Nadalini; Alessandra Chiuch; Leonardo A Sechi
Journal:  Diabetes Care       Date:  2007-06-15       Impact factor: 19.112

7.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

8.  Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.

Authors:  Rhonda Bentley-Lewis; Gail K Adler; Todd Perlstein; Ellen W Seely; Paul N Hopkins; Gordon H Williams; Rajesh Garg
Journal:  J Clin Endocrinol Metab       Date:  2007-08-28       Impact factor: 5.958

9.  Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.

Authors:  Erik Ingelsson; Michael J Pencina; Geoffrey H Tofler; Emelia J Benjamin; Katherine J Lanier; Paul F Jacques; Caroline S Fox; James B Meigs; Daniel Levy; Martin G Larson; Jacob Selhub; Ralph B D'Agostino; Thomas J Wang; Ramachandran S Vasan
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690

10.  Human adipocytes secrete mineralocorticoid-releasing factors.

Authors:  M Ehrhart-Bornstein; V Lamounier-Zepter; A Schraven; J Langenbach; H S Willenberg; A Barthel; H Hauner; S M McCann; W A Scherbaum; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

View more
  7 in total

Review 1.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

Review 2.  Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.

Authors:  Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

3.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

Review 4.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 5.  Heart fat in HIV: marker or mediator of risk?

Authors:  Jonathan Buggey; Chris T Longenecker
Journal:  Curr Opin HIV AIDS       Date:  2017-11       Impact factor: 4.283

6.  RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Kimberly Wong; Martin Torriani; Caitlin Mayhew; Takara Stanley; Janet Lo; Gail K Adler; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2015-06-18       Impact factor: 5.958

Review 7.  Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.

Authors:  Suman Srinivasa; Teressa S Thomas; Meghan N Feldpausch; Gail K Adler; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.